Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CPRX
#4033
Catalyst Pharmaceuticals, Inc. - Common Stock
0.3
1
USD
-99.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.00%
Monthly Change
-98.89%
6 month change
-98.65%
Year Change
-98.53%
Previous Close
31.2
9
Open
0.3
1
Low
0.3
1
High
0.3
1
Volume
206
Markets
US Stock Market
Healthcare
CPRX
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
103.82 M
102.74 M
105.65 M
117.86 M
121.45 M
122.12 M
122.38 M
Valuation ratios
Enterprise value
216.54 M
524.14 M
1.61 B
1.88 B
2.02 B
2.14 B
3.07 B
Price to earnings ratio
4.7
18.3
24.08
27.16
15.93
13.89
18.06
Price to sales ratio
2.98
5.18
9.39
4.89
5.3
5.04
6.66
Price to cash flow ratio
7.88
12.09
17.33
13.55
10.87
14.23
19.1
Price to book ratio
2.09
3.53
6.7
5.02
3.58
3.11
1.06
Enterprise value to EBITDA ratio
5.23
9.97
15.78
15.7
7.46
6.43
7.68
Profitability ratios
Return on assets %
0.39
0.17
0.22
0.15
0.19
0.19
0.06
Return on equity %
0.44
0.19
0.28
0.18
0.23
0.22
0.06
Return on invested capital %
1 733.34
516.79
783.31
168.59
244.3
314.74
87.43
Gross margin %
85.69
84.46
83.94
86.95
86
85.19
90.31
Operating margin %
34.69
37.2
47.54
21.8
39.68
43.77
49.02
EBITDA margin %
34.76
37.33
47.61
30.06
54.96
56.56
62.06
Net margin %
62.97
28.03
38.79
17.93
33.33
36.39
42.66
Liquidity ratios
Quick ratio
6.79
7.47
5.45
2.68
5.01
5.82
6.84
Current ratio
7
7.76
5.57
2.88
5.17
6.08
7.1
Inventory turnover
5.16
3.5
4.69
4.63
3.91
2.35
0.4
Asset turnover
0.78
0.65
0.7
0.94
0.74
0.53
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.42
0.56
1.04
1.26
1.92
1.64
1.64
EBIT per share
0.39
0.49
0.9
0.76
1.86
2.32
2.4
EBITDA per share
0.39
0.49
0.92
1.05
2.16
2.62
3.14
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.32
1.77
2.68
1.21
4.14
5.57
5.96
Net current asset value per share
1.5
1.95
2.88
1.93
4.99
7.03
7.41
Tangible book value per share
1.6
1.92
2.7
3.41
5.82
6.46
7.02
Working capital per share
1.28
1.7
2.36
1.26
4.03
5.87
6.37
Book value per share
1.6
1.92
2.7
3.41
5.82
7.5
7.98
News
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
CPRX or UTHR: Which Is the Better Value Stock Right Now?
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y
Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y
UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook
ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth
Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up
RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Seeking Clues to Catalyst (CPRX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics